FDA Gets Over 21,000 Medical Device Reports, Including 124 Deaths, Linked to Philips Foam Breakdown
The FDA updated a safety communication regarding medical device reports associated with the breakdown of materials used in Philips devices.
The FDA updated a safety communication regarding medical device reports associated with the breakdown of materials used in Philips devices.
N95 respirators met the primary endpoints of function and effectiveness, in addition to maintaining filtration efficiencies of 95% or more in the study.
Philips announces a repair and replacement program for specific Philips Bi-Level PAP, CPAP, and mechanical ventilators related to a voluntary recall of the PE-PUR sound abatement foam in these devices.
The FDA updated a safety communication regarding medical device reports associated with the breakdown of materials used in Philips devices.
“The study showed that through the use of NAVA, the days on mechanical ventilation could be reduced from 12 to 8 days, a four-day reduction or close to 35%.”
Read MoreMedical technology manufacturer Hillrom has launched two new respiratory therapy devices: the Volara System, which provides hospital-grade oscillation and lung expansion therapy, and the Synclara Cough System.
Read MoreThe global market for anesthesia and respiratory devices is slated to grow from $25.21 billion to $38.29 billion by 2023, surging at a compound annual growth rate of 7.2%. Driving market growth are the rise in respiratory diseases, an increase in surgical procedures, and high rates of tobacco consumption.
Read MoreUS Med-Equip primarily serves hospitals and long-term acute care centers, renting to them a wide range of moveable equipment across various clinical applications, including respiratory, infusion, patient monitoring, and neonatal. The company was chosen for the award from among hundreds of HealthTrust vendors included in the medical-surgical category.
Read More